Founders Financial Securities LLC Invests $2.48 Million in Marsh & McLennan Companies, Inc. $MRSH

Founders Financial Securities LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the fourth quarter, HoldingsChannel.com reports. The fund bought 13,382 shares of the financial services provider’s stock, valued at approximately $2,483,000.

Other institutional investors have also recently modified their holdings of the company. Numerai GP LLC grew its stake in shares of Marsh & McLennan Companies by 966.2% in the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after acquiring an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd grew its stake in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after acquiring an additional 11,648 shares during the last quarter. Rockland Trust Co. grew its stake in shares of Marsh & McLennan Companies by 801.6% in the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after acquiring an additional 10,734 shares during the last quarter. Barclays PLC boosted its position in shares of Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after buying an additional 647,987 shares during the last quarter. Finally, Bridges Investment Management Inc. boosted its position in shares of Marsh & McLennan Companies by 4.4% during the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock valued at $15,356,000 after buying an additional 3,177 shares during the last quarter. 87.99% of the stock is owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Stock Performance

MRSH stock opened at $159.73 on Monday. Marsh & McLennan Companies, Inc. has a fifty-two week low of $157.74 and a fifty-two week high of $235.78. The firm has a 50-day moving average price of $164.87. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market capitalization of $77.17 billion, a P/E ratio of 19.97, a price-to-earnings-growth ratio of 2.33 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies’s revenue for the quarter was up 7.6% compared to the same quarter last year. Equities analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Mizuho dropped their price objective on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a research report on Monday, April 13th. Piper Sandler dropped their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Raymond James Financial raised Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective on the stock in a research report on Tuesday, February 17th. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Finally, Barclays dropped their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $203.56.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.